52 related articles for article (PubMed ID: 8371283)
1. Effect of methylprednisolone on coagulation.
Pandit HB; Spillert CR
J Natl Med Assoc; 1999 Aug; 91(8):453-6. PubMed ID: 12656434
[TBL] [Abstract][Full Text] [Related]
2. Deceptive prothrombin and activated partial thromboplastin times in alcoholic cirrhosis.
Sirikonda PR; Spillert CR; Koneru B; Ponnudurai R; Wilson DJ; Lazaro EJ
J Natl Med Assoc; 1996 May; 88(5):306-9. PubMed ID: 8667440
[TBL] [Abstract][Full Text] [Related]
3. The modified recalcification time (MRT) assesses prothrombophlebitic role of conjugated estrogen (premarin).
Erhard H; Spillert CR; Ponnudurai R; Bonthu S; Lazaro EJ
Inflamm Res; 1995 Aug; 44 Suppl 2():S215. PubMed ID: 8548406
[No Abstract] [Full Text] [Related]
4. Modified recalcification time (MRT): a model to assess drug-induced depressed immune function.
Wamsteker E; Spillert CR; Ponnudurai R; Bonthu S; Slimowitz R; Lazaro EJ
Inflamm Res; 1995 Aug; 44 Suppl 2():S202. PubMed ID: 8548399
[No Abstract] [Full Text] [Related]
5. Digoxin and endotoxin: a lethal pro-inflammatory combination.
Tichansky DS; Spillert CR; Ponnudurai R; Bonthu S; Lazaro EJ
Inflamm Res; 1995 Aug; 44 Suppl 2():S201. PubMed ID: 8548398
[No Abstract] [Full Text] [Related]
6. Endotoxin negates anticoagulant effect of cyclosporine.
Spillert CR; Bonthu S; Ponnudurai R; Miller MA; Lazaro EJ
Inflamm Res; 1995 Aug; 44 Suppl 2():S197. PubMed ID: 8548395
[No Abstract] [Full Text] [Related]
7. The modified recalcification time (MRT) test assesses suppressive effect of general anesthesia (GA) on monocyte function.
Ponnudurai R; Ramasubramaniam H; Spillert CR; Bonthu S; Lazaro EJ
Inflamm Res; 1995 Aug; 44 Suppl 2():S193. PubMed ID: 8548393
[No Abstract] [Full Text] [Related]
8. Procoagulant property of platelet activating factor (PAF).
Raff GW; Spillert CR; Wilson DJ; Lazaro EJ
Agents Actions; 1993; 39 Spec No():C106. PubMed ID: 8273543
[TBL] [Abstract][Full Text] [Related]
9. Prothrombotic effects of endothelin-2 (ET-2).
Raff GW; Spillert CR; Wilson DJ; Lazaro EJ
Agents Actions; 1993; 39 Spec No():C104-5. PubMed ID: 8273542
[TBL] [Abstract][Full Text] [Related]
10. Coagulation effects of cyclosporine in liver transplantation.
Ferrante RJ; Spillert CR; Wilson DJ; Lazaro EJ
Agents Actions; 1993; 39 Spec No():C102-3. PubMed ID: 8273541
[TBL] [Abstract][Full Text] [Related]
11. Hypertension-related coronary thrombosis: prothrombic role of angiotensin II.
Spillert CR; Sun S; Miller MA; Lazaro EJ
J Natl Med Assoc; 1994 Sep; 86(9):686-8. PubMed ID: 7966432
[TBL] [Abstract][Full Text] [Related]
12. Laboratory evaluation of hemostatic disorders.
Hassouna HI
Hematol Oncol Clin North Am; 1993 Dec; 7(6):1161-249. PubMed ID: 8294314
[TBL] [Abstract][Full Text] [Related]
13. The investigation of a heart valve patient with suspected hypercoagulability.
Gough SC; Prentice CR
J Heart Valve Dis; 1993 Jan; 2(1):7-17. PubMed ID: 8269113
[TBL] [Abstract][Full Text] [Related]
14. Modified recalcification time: a global coagulation screening test.
Spillert CR; Lazaro EJ
J Natl Med Assoc; 1993 Aug; 85(8):611-6. PubMed ID: 8371283
[TBL] [Abstract][Full Text] [Related]
15. Modified recalcification time (MRT): a sensitive cancer test? Review of the evidence.
Spillert CR; Lazaro EJ
J Natl Med Assoc; 1995 Sep; 87(9):687-92. PubMed ID: 9583965
[TBL] [Abstract][Full Text] [Related]
16. Are hypertensives hypercoagulable?
Miller MA; Spillert CR; Ponnudurai R; Bonthu S; Lazaro EJ
J Natl Med Assoc; 1995 Jan; 87(1):71-2. PubMed ID: 7869410
[TBL] [Abstract][Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
